| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| CANC | CANC_TOPO(C570)_MORPHO(8461)_BEH(3) | Fallopian tube, Serous surface papillary carcinoma (C56.9) | 105 | |
| CANC | CANC_TOPO(C574)_MORPHO(8461)_BEH(3) | Uterine adnexa, Serous surface papillary carcinoma (C56.9) | 30 | |
| DEATH | DEATH_ICD10(C570) | Fallopian tube | 25 | |
| CANC | CANC_TOPO(C579)_MORPHO(8461)_BEH(3) | Female genital tract, NOS, Serous surface papillary carcinoma (C56.9) | 23 | |
| CANC | CANC_TOPO(C570)_MORPHO(8441)_BEH(3) | Fallopian tube, Serous cystadenocarcinoma, NOS | 15 | |
| DEATH | DEATH_ICD10(C579) | Female genital organ, unspecified | 15 | |
| DEATH | DEATH_ICD10(C578) | Overlapping lesion of female genital organs | 10 | |
| CANC | CANC_TOPO(C570)_MORPHO(8380)_BEH(3) | Fallopian tube, Endometrioid adenocarcinoma, NOS | 9 | |
| CANC | CANC_TOPO(C570)_MORPHO(8140)_BEH(3) | Fallopian tube, Adenocarcinoma, NOS | 8 | |
| CANC | CANC_TOPO(C579)_MORPHO(8000)_BEH(3) | Female genital tract, NOS, Neoplasm, malignant | 6 | |
| CANC | CANC_TOPO(C579)_MORPHO(8140)_BEH(3) | Female genital tract, NOS, Adenocarcinoma, NOS | 6 |